Metis Global Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Metis Global Partners's AMGN Position: Q1 2026 in Review
Metis Global Partners reduced its Amgen (AMGN) stake by 6.8% in Q1 2026, selling an estimated $578K and leaving 22,052 shares worth $7.76M. The position accounts for 0.19% of the portfolio, ranked #90.
Metis Global Partners first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.19M in Q1 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Metis Global Partners held 22,052 shares of Amgen worth $7.76M as of Q1 2026.
- Metis Global Partners sold 1,621 Amgen shares in Q1 2026, an estimated $578K.
- Amgen made up 0.19% of Metis Global Partners's portfolio in Q1 2026, its #90 holding.
- Metis Global Partners first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
- Metis Global Partners's Amgen position peaked at $9.19M in Q1 2025.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.